This publication summarizes the presentations and discussions from the workshop. The science around transmission of SARS-CoV-2, the virus that causes COVID-19, is complex and evolving quickly. For ...

In total, 5% of dogs and 13% of cats tested positive for COVID-19 on polymerase chain reaction, and 25% and 36%, respectively ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

Despite widespread exposure, residents in a Kentucky nursing home in 2023 did not contract mpox from an infected worker, ...

New Jersey-based biotechnology company, Grignard Pure LLC, a leader in developing next-generation indoor air treatment ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...